The short answer: the ibogaine programs worth comparing seriously are the ones that can document a thorough cardiac workup before dosing, continuous telemetry monitoring during and after dosing, a physician-led team that understands the noribogaine tail, and a clearly defined length of monitored stay. Marketing language, ceremony aesthetics, and price are secondary to these clinical fundamentals. This article is educational and is not medical advice; any decision about ibogaine treatment should be made with your own physician and only after a full medical evaluation.
Ibogaine comparison shopping tends to start in the wrong place. Prospective clients often begin by looking at photographs of a villa, reading testimonials, or comparing the number of nights included in a package. Those details are not irrelevant, but they say very little about whether a program is equipped to manage the specific physiological risk that ibogaine carries. Ibogaine is not a gentle plant tea taken in a circle; it is a potent alkaloid that acts on cardiac conduction in ways that are well documented in the clinical literature on this compound, and the single variable that separates a well-run program from a poorly run one is how seriously that risk is treated from intake through discharge. This guide walks through nine areas worth comparing directly, in the order they typically come up during a real due-diligence conversation, so you have specific questions to bring to any program rather than a general sense of what "safety" is supposed to mean.
1–3: Cardiac Screening, Monitoring, and Emergency Readiness
1. What does the pre-treatment cardiac workup actually include? Ask whether a program requires a resting ECG, electrolyte panel, and a full medical history review before approving a candidate, and whether a physician — not only an intake coordinator — makes the final decision. Programs that skip or rush this step are taking on risk they are not equipped to manage.
A thorough workup usually takes place over more than a single phone call. Expect a program to request recent lab work, a cardiologist's note if you have any prior cardiac history, and a detailed list of every medication and supplement you currently take, since several common drug classes are known to prolong cardiac conduction intervals in ways that can compound ibogaine's own effect on the heart. A vague answer sounds like "we review your intake form and let you know." A specific answer names the exact tests ordered, states who interprets them, and explains what happens if a result falls outside the range the program considers acceptable — including the possibility of being declined. Ask, too, how far in advance of travel this workup needs to be complete, since some cardiac tests are only useful if they are recent, and a program that lets this slide until arrival day has less real opportunity to catch a problem before you have already traveled.
2. Is there continuous cardiac telemetry during dosing? Because ibogaine can affect the heart's electrical conduction, continuous monitoring during and immediately after dosing is a core safety feature, not an optional extra. Ask how the telemetry is read, by whom, and how quickly a physician can respond if a reading changes.
It is worth understanding, at a basic level, why this matters so much specifically for ibogaine. The compound is associated with changes to the heart's electrical recovery cycle, and those changes can persist well beyond the point at which someone feels subjectively normal again. This is why "monitoring" needs to mean an actual continuous read-out reviewed by a person qualified to interpret it, not a nurse periodically checking a pulse oximeter clipped to a finger. Ask what equipment is used, whether it produces a continuous strip a physician can review, and whether that physician is trained specifically in reading cardiac rhythms — a general practitioner and a cardiologist do not necessarily have the same depth of experience spotting the subtle changes that matter here. A program that can answer this question with specifics, including brand of equipment and physician qualifications, is showing you something meaningfully different from one that says only "we monitor everyone closely."
3. What is the emergency plan if something goes wrong? Ask about on-site resuscitation equipment, the distance to the nearest hospital capable of managing a cardiac event, and whether a physician is on site or only on call. Reviewing our overview of ibogaine cardiac safety screening is a useful starting point for questions to bring to any program you are comparing.
Beyond the equipment itself, ask what the actual escalation pathway looks like. Who makes the call to intervene, what interventions are available on site, and what happens if a situation requires transfer to a hospital? A program should be able to describe, in plain language, the sequence of decisions and actions that would follow an abnormal reading — not just assure you that "we are prepared." It is reasonable to ask how far the nearest hospital capable of managing a cardiac event actually is in drive time, not just in kilometers, and whether that route has been tested rather than assumed. None of this is meant to frighten anyone away from treatment; it is meant to make the comparison concrete instead of aspirational.
4–6: The Noribogaine Tail, Length of Stay, and Exclusion Criteria
4. How long does monitored observation continue after dosing? Ibogaine is metabolized into noribogaine, an active compound with a long half-life that can continue to affect cardiac rhythm for days. Ask specifically how long a program keeps clients under monitoring for this tail period, not just for the acute dosing window.
Noribogaine's long half-life is one of the most commonly misunderstood parts of ibogaine treatment, and it is exactly the kind of detail that separates a serious comparison from a superficial one. Because this metabolite lingers in the body well after the dosing session has ended, the period of highest apparent drama — the hours immediately following the dose — is not necessarily the period of highest cardiac risk. A program that discharges someone or reduces monitoring as soon as the acute psychoactive effects fade is treating the wrong window as the risk window. Ask directly: how many days does continuous or near-continuous cardiac monitoring continue after dosing, and does that timeline reflect noribogaine's known pharmacokinetics or simply match the length of a typical hotel stay? A precise answer will name a specific number of days and explain the reasoning; a vague answer will say something like "we keep an eye on everyone" without committing to a duration.
5. What medical or psychiatric conditions would exclude a candidate? A serious program will name conditions that disqualify someone from ibogaine treatment, such as certain cardiac abnormalities, and will not accept every applicant. Ask what those exclusions are and how thoroughly they are screened for before travel.
A program willing to turn away applicants is, somewhat counterintuitively, a positive sign. Ibogaine is not appropriate for everyone, and certain cardiac abnormalities, some medication combinations, and specific psychiatric presentations can make treatment genuinely unsafe regardless of how closely someone is monitored afterward. Ask what proportion of applicants are typically declined at intake, whether that decision is made by a physician rather than a sales or admissions team, and what alternative guidance is offered to someone who is declined. A program that accepts virtually everyone who inquires is not necessarily being kind; it may simply not be screening rigorously, and that should factor heavily into any comparison.
6. How is the overall length of stay structured? Compare whether a program treats the dosing session as an isolated event or embeds it within a longer, medically supervised stay with preparation and follow-up. Our page on how ibogaine treatment works outlines what a fuller process typically involves.
Think of length of stay as a proxy for how a program conceptualizes ibogaine treatment overall. A program that treats dosing as a single isolated event, arranged around a short visit, is implicitly treating the medicine as the whole intervention. A program that builds in preparation days beforehand and observation and integration days afterward is treating the dosing session as one part of a longer clinical process. Neither framing guarantees a particular result, but the second one generally allows more time for a cardiac issue to surface and be caught, and more time for the person to process what can be an intense experience before returning home. When comparing total length of stay across programs, look past the marketed number of nights and ask what each day is actually structured to accomplish.
7–8: Staffing, Licensing, and Transparency on Cost
7. Who is the physician responsible for clinical decisions, and what is their role during dosing? Ask for a name, a credential, and whether that person is physically present during the dosing session itself, or only reachable by phone.
There is a meaningful difference between a program that lists a "medical director" on its website and one where that physician is the person actually in the room, reading the telemetry, and making real-time decisions. Ask for the physician's name outright, and ask what happens on the (hopefully rare) occasion when that physician is unavailable — is there a qualified backup, or does coverage lapse? It is also reasonable to ask about the broader clinical team: how many staff members are trained to recognize a cardiac event, what their specific roles are during a dosing session, and how the team communicates with each other if something needs to escalate quickly. A program with one physician overseeing many simultaneous clients is a different operation from one with a physician dedicated to a single client at a time during the highest-risk window.
8. Is the facility licensed, and by whom? Ask which regulator licenses the facility. Sanctuary Tulum is licensed by COFEPRIS, Mexico's federal health regulator, which is a claim that can be independently checked. Ask the same question of any program you are considering, and read more about the full range of therapies offered alongside ibogaine treatment to understand what surrounds the dosing session itself.
Licensing itself is a fact you can independently verify rather than take on faith, and doing so is a reasonable step before traveling for treatment. Ask which specific regulator licenses the facility, request the license number or documentation if it is available, and consider whether the program is transparent about this or evasive when asked directly. A facility that is licensed by a recognized regulator is operating under external oversight that carries real consequences for failing to meet standards; a facility that describes itself only in general terms as "medically supervised" without naming a regulator is asking you to take that description on faith alone.
9: What Is Actually Included in the Price
9. What is included in the quoted price, and what costs extra? Ask for a written breakdown covering accommodation, physician time, laboratory work, monitoring, meals, and follow-up support. Then ask what typically triggers additional charges — extended monitoring, additional laboratory work, or an extended stay if the medical team recommends one. Our guide to ibogaine treatment cost walks through the categories most programs bill separately.
Price comparisons across ibogaine programs are notoriously difficult because the underlying scope of what is being sold varies so widely. A quoted figure at one program might include a full cardiac workup, several days of continuous telemetry, a private physician, and an extended observation period covering the noribogaine tail. The same figure at another program might cover only a shared room and a single dosing session with minimal monitoring. Before comparing two numbers side by side, ask each program to itemize exactly what is included, and specifically ask whether extended monitoring — should the medical team recommend it based on how you respond — is covered in the quoted price or billed as an add-on. A program that is upfront about the conditions under which costs could increase, and why, is generally more trustworthy than one that presents a single flat number with no explanation of what triggers a change.
Comparing programs on these nine points takes longer than comparing photographs of a treatment suite, but it is the comparison that actually reflects how safely a program is prepared to manage ibogaine's known cardiac effects. If you want to talk through your specific medical history before deciding, our team is reachable through the contact page, and our ibogaine resource library has further reading.
A Short Checklist to Take Into Every Conversation
- Written description of the pre-treatment cardiac workup, including ECG and labs
- Confirmation of continuous telemetry monitoring during dosing
- Stated length of monitored observation covering the noribogaine tail
- Named exclusion criteria and how thoroughly candidates are screened
- Named physician and their physical presence during dosing
- Named licensing regulator
- Itemised pricing with likely additional charges disclosed upfront
- Clear escalation pathway and named distance to the nearest capable hospital
- Willingness to decline unsuitable candidates rather than accept everyone who inquires
None of these nine points can be fully verified from a website alone, which is exactly why they are worth raising directly in a conversation with admissions staff and, ideally, with the medical team itself before you commit to travel. A program confident in its own safety infrastructure will generally welcome detailed questions rather than deflect them, and the quality of those answers — specific, documented, and willing to name limits — tends to say more about a program than anything in its marketing materials.
Educational content only. This article does not diagnose, treat, or replace care from a licensed physician, and nothing here is a promise of any particular outcome. Never start, stop, or change a prescribed medication without medical supervision.
